Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.
Trends Immunol. 2012 Nov;33(11):554-62. doi: 10.1016/j.it.2012.07.001. Epub 2012 Aug 3.
Highly active antiretroviral therapy (HAART) suppresses HIV-1 replication, transforming the outlook for infected patients. However, reservoirs of replication-competent forms of the virus persist during HAART, and when treatment is stopped, high rates of HIV-1 replication return. Recent insights into HIV-1 latency, as well as a report that HIV-1 infection was eradicated in one individual, have renewed interest in finding a cure for HIV-1 infection. Strategies for HIV-1 eradication include gene therapy and hematopoietic stem cell transplantation, stimulating host immunity to control HIV-1 replication, and targeting latent HIV-1 in resting memory CD4(+) T cells. Future efforts should aim to provide better understanding of how to reconstitute the CD4(+) T cell compartment with genetically engineered cells, exert immune control over HIV-1 replication, and identify and eliminate all viral reservoirs.
高效抗逆转录病毒疗法(HAART)抑制 HIV-1 复制,改变了感染患者的预后。然而,在 HAART 期间,复制能力的病毒储库仍然存在,当治疗停止时,HIV-1 复制会迅速恢复。最近对 HIV-1 潜伏期的深入了解,以及一份报告称 HIV-1 感染已在一个个体中被消除,重新激发了寻找 HIV-1 感染治愈方法的兴趣。HIV-1 清除策略包括基因治疗和造血干细胞移植,刺激宿主免疫以控制 HIV-1 复制,并针对静息记忆 CD4(+)T 细胞中的潜伏 HIV-1。未来的努力应旨在更好地理解如何用基因工程细胞重建 CD4(+)T 细胞群,对 HIV-1 复制进行免疫控制,并确定和消除所有病毒库。